NASDAQ:LSBPW LakeShore Biopharma Co., Ltd - Warrants (LSBPW) Stock Price, News & Analysis $0.03 0.00 (0.00%) As of 08/21/2025 Add Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestTrendsBuy This Stock About LakeShore Biopharma Co., Ltd - Warrants Stock (NASDAQ:LSBPW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LSBPW alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.03▼$0.0452-Week Range$0.01▼$0.11VolumeN/AAverage Volume29,093 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview LakeShore Biopharma Co., Ltd. is a Cayman Islands–incorporated, clinical-stage biopharmaceutical company headquartered in Suzhou, China. The company is dedicated to the discovery, development and commercialization of innovative therapies, with a primary focus on immuno-oncology and fibrotic diseases. Leveraging an in-licensing strategy, LakeShore acquires early-stage drug candidates from academic institutions and biotechnology partners, then advances them through preclinical research and clinical trials using its integrated R&D platforms. The company’s pipeline comprises both small molecule and biologic candidates that target mechanisms such as tumor microenvironment modulation, ferroptosis induction and anti-fibrotic pathways. Through its fully equipped facilities in Suzhou, LakeShore conducts host biology profiling, bioanalysis and process development in support of its lead programs. These efforts are complemented by collaborations with global research institutions, which provide access to specialized expertise and enable efficient progression of assets toward clinical proof-of-concept. LakeShore Biopharma serves domestic and international markets via strategic partnerships designed to facilitate global development and future commercialization. The company completed its initial public offering on the Nasdaq Global Market in mid-2023, issuing ordinary shares and corresponding warrants that trade under the symbol LSBPW. Backed by a leadership team with deep experience in drug discovery, clinical development and regulatory affairs, LakeShore is positioned to advance its key assets toward potential regulatory submissions and commercial milestones.AI Generated. May Contain Errors. Read More Receive LSBPW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LakeShore Biopharma Co., Ltd - Warrants and its competitors with MarketBeat's FREE daily newsletter. Email Address LSBPW Stock News HeadlinesLSBPW LakeShore Biopharma Co., Ltd C/WTS 15/03/28 (TO PUR ORD)August 7, 2025 | seekingalpha.comSee More Headlines LSBPW Stock Analysis - Frequently Asked Questions How have LSBPW shares performed this year? LakeShore Biopharma Co., Ltd - Warrants' stock was trading at $0.0660 at the beginning of the year. Since then, LSBPW stock has decreased by 59.1% and is now trading at $0.0270. How do I buy shares of LakeShore Biopharma Co., Ltd - Warrants? Shares of LSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:LSBPW CIK1946399 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$614.96 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:LSBPW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LakeShore Biopharma Co., Ltd - Warrants Please log in to your account or sign up in order to add this asset to your watchlist. Share LakeShore Biopharma Co., Ltd - Warrants With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.